DEFB127
gene geneOn this page
Also known as bA530N10.2DEF-27
Summary
DEFB127 (defensin beta 127, HGNC:16206) is a protein-coding gene on chromosome 20p13, encoding Beta-defensin 127 (Q9H1M4). Has antibacterial activity.
Defensins are cysteine-rich cationic polypeptides that are important in the immunologic response to invading microorganisms. The antimicrobial protein encoded by this gene is secreted and is a member of the beta defensin protein family. Beta defensin genes are found in several clusters throughout the genome, with this gene mapping to a cluster at 20p13.
Source: NCBI Gene 140850 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 15 total
- MANE Select transcript:
NM_139074
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16206 |
| Approved symbol | DEFB127 |
| Name | defensin beta 127 |
| Location | 20p13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bA530N10.2, DEF-27 |
| Ensembl gene | ENSG00000088782 |
| Ensembl biotype | protein_coding |
| Entrez | 140850 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000382388
RefSeq mRNA: 1 — MANE Select: NM_139074
NM_139074
CCDS: CCDS12991
Canonical transcript exons
ENST00000382388 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001166560 | 158774 | 159163 |
| ENSE00001491947 | 157454 | 157593 |
Expression profiles
Bgee: expression breadth broad, 12 present calls, max score 99.25.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1723 / max 296.3844, expressed in 4 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 182987 | 0.1046 | 3 |
| 182988 | 0.0510 | 2 |
| 182989 | 0.0116 | 2 |
| 182986 | 0.0052 | 1 |
Top tissues by expression
238 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| corpus epididymis | UBERON:0004359 | 99.25 | gold quality |
| cauda epididymis | UBERON:0004360 | 94.82 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.67 | silver quality |
| caput epididymis | UBERON:0004358 | 69.93 | gold quality |
| tibialis anterior | UBERON:0001385 | 63.60 | silver quality |
| ileal mucosa | UBERON:0000331 | 60.96 | silver quality |
| pancreatic ductal cell | CL:0002079 | 60.74 | silver quality |
| buccal mucosa cell | CL:0002336 | 60.71 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 54.74 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| deltoid | UBERON:0001476 | 51.67 | gold quality |
| myocardium | UBERON:0002349 | 50.25 | gold quality |
| cerebellar vermis | UBERON:0004720 | 48.93 | gold quality |
| quadriceps femoris | UBERON:0001377 | 47.89 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 47.03 | gold quality |
| vastus lateralis | UBERON:0001379 | 45.40 | gold quality |
| thymus | UBERON:0002370 | 44.61 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 43.55 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| upper leg skin | UBERON:0004262 | 43.27 | silver quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| muscle tissue | UBERON:0002385 | 41.65 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 41.64 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| cartilage tissue | UBERON:0002418 | 40.77 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.48 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
10 targeting DEFB127, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-7856-5P | 99.75 | 69.99 | 2901 |
| HSA-MIR-4325 | 99.49 | 72.20 | 1342 |
| HSA-MIR-4477B | 99.23 | 70.49 | 1733 |
| HSA-MIR-1253 | 99.12 | 67.08 | 1688 |
| HSA-MIR-7702 | 99.06 | 65.95 | 698 |
| HSA-MIR-6770-5P | 98.97 | 66.76 | 1853 |
| HSA-MIR-493-3P | 97.50 | 66.44 | 731 |
| HSA-MIR-3974 | 96.56 | 66.22 | 928 |
| HSA-MIR-548AD-3P | 94.39 | 66.04 | 350 |
Literature-anchored findings (GeneRIF, showing 2)
- The protein encoded by this gene is thought to display antimicrobial activity. (PMID:12620395)
- Genome-wide association study on coronary artery disease in type 1 diabetes suggests beta-defensin 127 as a risk locus. (PMID:32077919)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Defb22 | ENSMUSG00000027468 |
| rattus_norvegicus | Defb22 | ENSRNOG00000007525 |
Paralogs (19): DEFB129 (ENSG00000125903), DEFB118 (ENSG00000131068), DEFB104A (ENSG00000176782), DEFB104B (ENSG00000177023), DEFB125 (ENSG00000178591), DEFB124 (ENSG00000180383), DEFB123 (ENSG00000180424), DEFB119 (ENSG00000180483), DEFB108B (ENSG00000184276), DEFB128 (ENSG00000185982), DEFB131A (ENSG00000186146), DEFB132 (ENSG00000186458), DEFB121 (ENSG00000204548), DEFB134 (ENSG00000205882), DEFB135 (ENSG00000205883), DEFB108C (ENSG00000215371), DEFB116 (ENSG00000215545), DEFB115 (ENSG00000215547), DEFB131B (ENSG00000225805)
Protein
Protein identifiers
Beta-defensin 127 — Q9H1M4 (reviewed: Q9H1M4)
Alternative names: Beta-defensin 27, Defensin, beta 127
All UniProt accessions (1): Q9H1M4
UniProt curated annotations — full annotation on UniProt →
Function. Has antibacterial activity.
Subcellular location. Secreted.
Similarity. Belongs to the beta-defensin family.
RefSeq proteins (1): NP_620713* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR025933 | Beta_defensin_dom | Domain |
| IPR050544 | Beta-defensin | Family |
Pfam: PF13841
UniProt features (9 total): disulfide bond 3, sequence variant 2, signal peptide 1, peptide 1, propeptide 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H1M4-F1 | 81.86 | 0.27 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (3): 24–53, 33–47, 37–54
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-1461957 | Beta defensins |
| R-HSA-1461973 | Defensins |
MSigDB gene sets: 16 (showing top):
REACTOME_INNATE_IMMUNE_SYSTEM, GOBP_ANTIMICROBIAL_HUMORAL_RESPONSE, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOBP_HUMORAL_IMMUNE_RESPONSE, GOBP_DEFENSE_RESPONSE_TO_GRAM_NEGATIVE_BACTERIUM, GOBP_DEFENSE_RESPONSE_TO_BACTERIUM, GOBP_RESPONSE_TO_BACTERIUM, MODULE_49, GOBP_ANTIMICROBIAL_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_ANTIMICROBIAL_PEPTIDE, REACTOME_ANTIMICROBIAL_PEPTIDES, MIR7856_5P, chr20p13, GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERSPECIES_INTERACTION_BETWEEN_ORGANISMS, GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_UP, REACTOME_DEFENSINS
GO Biological Process (5): defense response to bacterium (GO:0042742), innate immune response (GO:0045087), defense response to Gram-negative bacterium (GO:0050829), antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844), defense response (GO:0006952)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): extracellular region (GO:0005576)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Defensins | 1 |
| Antimicrobial peptides | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| defense response | 1 |
| response to bacterium | 1 |
| immune response | 1 |
| defense response to symbiont | 1 |
| defense response to bacterium | 1 |
| antimicrobial humoral response | 1 |
| response to stress | 1 |
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
300 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DEFB127 | DEFB125 | Q8N687 | 751 |
| DEFB127 | DEFB134 | Q4QY38 | 742 |
| DEFB127 | DEFB126 | Q9BYW3 | 720 |
| DEFB127 | DEFB114 | Q30KQ6 | 712 |
| DEFB127 | DEFB124 | Q8NES8 | 700 |
| DEFB127 | DEFB132 | Q7Z7B7 | 695 |
| DEFB127 | DEFB129 | Q9H1M3 | 690 |
| DEFB127 | DEFB135 | Q30KP9 | 672 |
| DEFB127 | DEFB118 | Q96PH6 | 665 |
| DEFB127 | DEFB110 | Q30KQ9 | 648 |
| DEFB127 | DEFB115 | Q30KQ5 | 643 |
| DEFB127 | DEFB116 | Q30KQ4 | 609 |
| DEFB127 | DEFB131A | P59861 | 590 |
| DEFB127 | DEFB113 | Q30KQ7 | 546 |
| DEFB127 | DEFB1 | P60022 | 520 |
IntAct
43 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DEFB127 | TFEC | psi-mi:“MI:0915”(physical association) | 0.560 |
| TFEC | DEFB127 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DEFB127 | CD79A | psi-mi:“MI:0915”(physical association) | 0.560 |
| DEFB127 | CPLX4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DEFB127 | PIANP | psi-mi:“MI:0915”(physical association) | 0.560 |
| DEFB127 | AQP6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BCL2L13 | DEFB127 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ASZ1 | DEFB127 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM174A | DEFB127 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DEFB127 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| CD79A | DEFB127 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CPLX4 | DEFB127 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PIANP | DEFB127 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MFSD14B | DEFB127 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MMGT1 | DEFB127 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EBP | DEFB127 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DEFB127 | AURKAIP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| AQP6 | DEFB127 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DEFB127 | DCTN6 | psi-mi:“MI:0914”(association) | 0.530 |
| COPS5 | FBLL1 | psi-mi:“MI:0914”(association) | 0.350 |
| DEFB127 | ASZ1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| DEFB127 | BCL2L13 | psi-mi:“MI:0915”(physical association) | 0.000 |
| DEFB127 | FAM174A | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (35): DEFB127 (Two-hybrid), HTRA1 (Affinity Capture-MS), ACTR10 (Affinity Capture-MS), DCTN6 (Affinity Capture-MS), DCTN5 (Affinity Capture-MS), SH3BGR (Affinity Capture-MS), DCTN3 (Affinity Capture-MS), DCTN4 (Affinity Capture-MS), ACTBL2 (Affinity Capture-MS), ACTR1B (Affinity Capture-MS), ACTR1A (Affinity Capture-MS), DCTN2 (Affinity Capture-MS), DEFB127 (Two-hybrid), DEFB127 (Two-hybrid), BCL2L13 (Two-hybrid)
ESM2 similar proteins: A4H220, A4H221, A4H222, A4H223, A4H225, A4H227, A4H228, A4H238, A4H240, A4H253, A4H254, A4H255, A4H257, A4H258, A4H259, A4H262, A4H263, A4H264, A4H265, P0C8A8, P0DY26, P0DY27, Q29RT9, Q30KJ7, Q30KK0, Q30KK1, Q30KK9, Q30KL1, Q30KL7, Q30KP3, Q30KP5, Q30KQ4, Q30KQ5, Q30KQ8, Q30KR1, Q30KT5, Q32P86, Q32ZH2, Q32ZH6, Q3UW43
Diamond homologs: A4H253, A4H254, A4H255, Q30KK1, Q30KP3, Q32ZH2, Q5J5Z9, Q7Z7B8, Q9H1M4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
15 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 14 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
61 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:158772:A:AG | acceptor_gain | 1.0000 |
| 20:158773:G:GG | acceptor_gain | 1.0000 |
| 20:157589:CACAG:C | donor_loss | 0.9900 |
| 20:157590:ACAG:A | donor_loss | 0.9900 |
| 20:157594:GTAA:G | donor_loss | 0.9900 |
| 20:158770:ATAG:A | acceptor_loss | 0.9900 |
| 20:158771:TAGT:T | acceptor_loss | 0.9900 |
| 20:158772:A:G | acceptor_loss | 0.9900 |
| 20:158773:GT:G | acceptor_gain | 0.9900 |
| 20:158773:GTA:G | acceptor_gain | 0.9900 |
| 20:157595:T:A | donor_loss | 0.9800 |
| 20:158765:T:A | acceptor_gain | 0.9800 |
| 20:158773:GTAA:G | acceptor_gain | 0.9800 |
| 20:158773:GTAAC:G | acceptor_gain | 0.9800 |
| 20:158767:T:TA | acceptor_gain | 0.9700 |
| 20:158770:A:AG | acceptor_gain | 0.9700 |
| 20:158771:T:G | acceptor_gain | 0.9700 |
| 20:157681:G:T | donor_gain | 0.9100 |
| 20:158775:A:AG | acceptor_gain | 0.9000 |
| 20:158771:TAGTA:T | acceptor_gain | 0.8900 |
| 20:158772:AGTAA:A | acceptor_gain | 0.8900 |
| 20:157657:G:T | donor_gain | 0.8800 |
| 20:158765:T:TA | acceptor_loss | 0.8800 |
| 20:158775:AACC:A | acceptor_gain | 0.8200 |
| 20:158769:TATAG:T | acceptor_gain | 0.8000 |
| 20:158770:ATAGT:A | acceptor_gain | 0.8000 |
| 20:157534:A:T | donor_gain | 0.7600 |
| 20:158815:G:T | acceptor_gain | 0.7600 |
| 20:158776:A:G | acceptor_gain | 0.7300 |
| 20:157594:G:GG | donor_gain | 0.6600 |
AlphaMissense
647 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:158799:G:C | W25C | 0.678 |
| 20:158799:G:T | W25C | 0.678 |
| 20:158826:G:C | R34S | 0.663 |
| 20:158826:G:T | R34S | 0.663 |
| 20:158863:T:A | C47S | 0.621 |
| 20:158864:G:C | C47S | 0.621 |
| 20:158790:G:C | K22N | 0.610 |
| 20:158790:G:T | K22N | 0.610 |
| 20:158794:T:A | C24S | 0.610 |
| 20:158795:G:C | C24S | 0.610 |
| 20:158884:T:A | C54S | 0.589 |
| 20:158885:G:C | C54S | 0.589 |
| 20:158815:G:A | G31R | 0.579 |
| 20:158815:G:C | G31R | 0.579 |
| 20:158794:T:C | C24R | 0.576 |
| 20:158833:T:A | C37S | 0.571 |
| 20:158834:G:C | C37S | 0.571 |
dbSNP variants (sampled 300 via entrez): RS1000042223 (20:155909 A>G), RS1001586049 (20:158757 C>A,T), RS1002010518 (20:158028 G>C), RS1003421155 (20:156806 A>G), RS1004329854 (20:159521 A>C), RS1006362868 (20:156804 C>T), RS1006698011 (20:158107 G>A,T), RS1006728884 (20:157822 T>C), RS1008361972 (20:159380 A>G), RS1008391048 (20:156036 T>C), RS1008402923 (20:159168 G>C,T), RS1009917852 (20:159412 T>C), RS1010812875 (20:157689 GC>G), RS1010927395 (20:157982 C>A,G), RS1011946279 (20:156762 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST011116_9 | Coronary artery disease in type 1 diabetes | 1.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Acetaminophen | decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.